Quarterly report pursuant to Section 13 or 15(d)

2017 REGISTERED DIRECT OFFERING (Details Textual)

v3.7.0.1
2017 REGISTERED DIRECT OFFERING (Details Textual) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Mar. 03, 2017
Feb. 24, 2017
Feb. 20, 2017
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Sep. 30, 2016
Sep. 28, 2016
Sep. 30, 2013
Repayments of Notes Payable           $ 1,000,000 $ 0      
Derivative Liability   $ 2,996,110                
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)       $ 65,326 $ 0 426,832 $ 192,128      
Common Stock [Member]                    
Stock Issued During Period, Shares, New Issues   10,166,664                
Massachusetts Life Sciences Center [Member]                    
Class of Warrant or Right, Exercise Price of Warrants or Rights                   $ 0.27
Qualified Financing, Minimum Net Proceeds                 $ 5,000,000  
Repayments of Notes Payable $ 830,000 $ 830,000                
REGISTERED DIRECT OFFERING 2017 [Member]                    
Shelf Registration Statement, Maximum Amount Authorized               $ 50,000,000    
Stock Issued During Period, Shares, New Issues     10,166,664              
Shares Issued, Price Per Share     $ 0.60              
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.75              
Stock Issued During Period, Value, New Issues   6,100,000                
Number Of Warrants Per Unit     0.55              
Cash Price Per Each Common Stock Underlying Warrants   0.18                
Allocation Of Remaining Proceeds To Common Stock And Additional Paid In Capital   3,103,888                
Payments of Stock Issuance Costs   112,000                
REGISTERED DIRECT OFFERING 2017 [Member] | Series F Warrant [Member]                    
Stock Issued During Period, Value, New Issues   $ 6,099,998                
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)       $ 65,326   $ 426,832